January 22, 2018
Novartis buys French radiopharmaceutical company AAA for $3.9 billion
Novartis Group France has completed a tender to buy Advanced Accelerator Applications S.A. for $3,9 billion, or $41.00 per ordinary…
Pharmaceuticals, Biotechnology and Life Sciences
Novartis Group France has completed a tender to buy Advanced Accelerator Applications S.A. for $3,9 billion, or $41.00 per ordinary…
Novartis said on Monday that it wants to buy Advanced Accelerator Applications (AAA), a radiopharmaceutical company that owns and sells…